It has been reported that pDCs and dDCs express the tolerogenic enzyme IDO1 in SLN of patients with melanoma (5,19,20), suggesting a crucial role of this enzyme in melanoma tolerance [13]. This evidence concerns the gene IDO1 and melanoma.